二叶式与三叶式主动脉瓣狭窄TAVR结局比较
基于二叶式主动脉瓣狭窄TAVR多中心注册研究,倾向性评分匹配后比较546对二叶式与三叶式主动脉瓣狭窄患者,二叶式组转外科手术更多、器械成功率更低,但2年全因死亡率相近;早期器械存在操作差异,新型器械则无差异。
要点
- 二叶式组转外科手术率2.0%高于三叶式组0.2%,器械成功率85.3%低于91.4%。
- 早期器械中,球囊扩张式器械二叶式组主动脉根部损伤4.5% vs 0.0%;自膨胀式器械中重度瓣周漏19.4% vs 10.5%。
- 新型器械中不同瓣膜操作结果相当,2年全因死亡率二叶式17.2% vs 三叶式19.4%,差异无统计学意义。
核心结论
- 与三叶式主动脉瓣狭窄相比,二叶式主动脉瓣狭窄行TAVR的预后相似,但器械成功率更低。
- 早期器械治疗的患者存在操作差异,而新型器械未观察到差异。
研究设计与样本
- 二叶式主动脉瓣狭窄TAVR多中心注册研究,比较561例二叶式与4546例三叶式主动脉瓣狭窄患者,倾向性评分匹配后组成546对基线特征相似的患者。
- 按瓣膜学术研究联盟-2(VARC-2)标准记录操作与临床结局。
主要发现
- 二叶式组转外科手术2.0% vs 三叶式组0.2%(p=0.006),器械成功率85.3% vs 91.4%(p=0.002)。
- 早期器械植入于二叶式320例与三叶式321例,新型器械植入于二叶式226例与三叶式225例。
- 早期器械组中,球囊扩张式器械二叶式组主动脉根部损伤4.5% vs 0.0%(p=0.015),自膨胀式器械中重度瓣周漏19.4% vs 10.5%(p=0.02)。
- 新型器械组中不同瓣膜的操作结果相当。
- 2年累积全因死亡率二叶式17.2% vs 三叶式19.4%(p=0.28)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transcatheter aortic valve replacement (TAVR) is being increasingly performed in patients with bicuspid aortic valve stenosis (AS). OBJECTIVES: This study sought to compare the procedural and clinical outcomes in patients with bicuspid versus tricuspid AS from the Bicuspid AS TAVR multicenter registry. METHODS: Outcomes of 561 patients with bicuspid AS and 4,546 patients with tricuspid AS were compared after propensity score matching, assembling 546 pairs of patients with similar baseline characteristics. Procedural and clinical outcomes were recorded according to Valve Academic Research Consortium-2 criteria. RESULTS: Compared with patients with tricuspid AS, patients with bicuspid AS had more frequent conversion to surgery (2.0% vs. 0.2%; p = 0.006) and a significantly lower device success rate (85.3% vs. 91.4%; p = 0.002). Early-generation devices were implanted in 320 patients with bicuspid and 321 patients with tricuspid AS, whereas new-generation devices were implanted in 226 and 225 patients with bicuspid and tricuspid AS, respectively. Within the group receiving early-generation devices, bicuspid AS had more frequent aortic root injury (4.5% vs. 0.0%; p = 0.015) when receiving the balloon-expanding device, and moderate-to-severe paravalvular leak (19.4% vs. 10.5%; p = 0.02) when receiving the self-expanding device. Among patients with new-generation devices, however, procedural results were comparable across different prostheses. The cumulative all-cause mortality rates at 2 years were comparable between bicuspid and tricuspid AS (17.2% vs. 19.4%; p = 0.28). CONCLUSIONS: Compared with tricuspid AS, TAVR in bicuspid AS was associated with a similar prognosis, but lower device success rate. Procedural differences were observed in patients treated with the early-generation devices, whereas no differences were observed with the new-generation devices.
引用
- Yoon SH, Bleiziffer S, De Backer O, et al. Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis. J Am Coll Cardiol. 2017. PMID: 28330793. doi:10.1016/j.jacc.2017.03.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。